Recorded Webinar
Governance is often overlooked and underutilized in early stage and emerging companies, but stronger oversight during these periods can be extremely valuable. You will learn the following during this webinar with Howard Brownstein & Wendy DiCicco:
Howard Browstein, Wendy DiCicco
September 7, 2018
12:00 PM ET
Individual & Corporate Members, please use your promo code to register complimentary. Cost for non-members to register is $50. To become a member, click here. The recording will be emailed to you after purchase.
President and Founder of The Brownstein Corporation
Howard Brod Brownstein is President and Founder of The Brownstein Corporation, a nationally-known turnaround and crisis management firm. Mr. Brownstein regularly serves as an independent board member, and he currently chairs the Nominating & Governance and Strategic Planning & Risk Assessment Committees of P&F Industries (NasdaqGM: PFIN), and also serves on the board of Merakey, a large nonprofit with more than 10,000 employees. He served until recently on the Board of A.M. Castle & Co. (OTMKTS: CASL), and was Audit Chair of PICO Holdings (Nasdaq: PICO). He previously served on the Board of LMG2, was the sole board member of Betsey Johnson LLC, was Audit Chair of Special Metals Corp., and served on the board of Magnatrax Corporation. He also was chairman of the National Philanthropic Trust, and served on the board of a regional bank, a retail department store, and was chairman of a United Way agency. He has published over eighty articles, books and chapters, on turnaround management and corporate governance.
Chief Operating and Chief Financial Officer of Centinel Spine
Ms. DiCicco is currently Chief Operating and Chief Financial Officer of Centinel Spine, a global, privately held developer and manufacturer of spinal implants, where she has been since August 2017. From 2014 through 2017, she served as President and Chief Operating Officer of Camber Spine, a privately held spinal implant company. Prior to her roles with Centinel and Camber, from 2008 through 2014, Ms. DiCicco served as Chief Financial Officer of several private, equity backed primarily biotech and medtech companies, including Globus Medical, Nuron Biotech and Quench. From 1996 to 2008, she served as the Chief Financial Officer of Kensey Nash Corporation, a publicly-traded medical technology company specializing in cardiology and orthopaedics and now part of Royal DSM, a Netherlands company. Ms. DiCicco was an Accounting and Audit Manager with Deloitte LLP from 1990 to 1996, where she served clients in the manufacturing and retail industries. Ms. DiCicco graduated from Philadelphia College of Textiles and Science with a B.S. degree in Accounting. Ms. DiCicco is a Certified Public Accountant in Pennsylvania and is a member of AICPA, the PICPA and the NACD. Her board service includes both private and public companies across the medical device and opto-electronic industries. Her private company board service includes SynCardia Systems, and her public company board service includes II-VI, Inc. and CannaPharma Rx. She has served on the boards of multiple non-profit organizations, including the Chester Springs Library, the Chester County Economic Development Council and the Upper Main Line YMCA as well as the Philadelphia Chapter of the NACD.
